Search Within

Nikolaus D Schultz

Formats
  1. Journal Article (296)
  2. Meeting Abstract (184)
  3. Editorial (4)
  4. Review (4)
  5. Book Section (1)
  6. Conference Paper (1)
  7. Research Letter (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (491)
  2. Computational Oncology Service (491)
  3. Epidemiology and Biostatistics (491)
  4. GSK Faculty (491)
  5. Human Oncology and Pathogenesis Program (491)
  6. Department of Medicine (345)

More Groups

People
  1. Michael Berger (157)
  2. David Solit (150)
  3. Jianjiong Gao (99)
  4. Walid Chatila (85)
  5. Marc Ladanyi (83)
  6. Chris Sander (81)

More People

Years
  1. 2025 (19)
  2. 2024 (40)
  3. 2023 (37)
  4. 2022 (55)
  5. 2021 (28)
  6. 2020 (48)

More Years

Publications
  1. Journal of Clinical Oncology (88)
  2. Cancer Research (53)
  3. Clinical Cancer Research (38)
  4. Nature (21)
  5. Nature Communications (20)
  6. Cancer Discovery (18)

More Publications

Publishers
  1. American Association for Cancer Research (113)
  2. American Society of Clinical Oncology (102)
  3. Nature Publishing Group (78)
  4. Oxford University Press (37)
  5. Cell Press (29)
  6. Elsevier Inc. (20)

More Publishers

Results (491)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mathematical modeling of tumor heterogeneity to optimize treatment scheduling and delay the evolution of resistance
    Meeting Abstract

    Mathur, D.; Taylor, B. P.; Chatila, W.; Schultz, N.; Razavi, P.; Xavier, J.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Specific mutations in APC, but not alterations in DNA damage response, associate with outcomes of patients with metastatic colorectal cancer
    Journal Article

    Mondaca, S.; Walch, H.; Nandakumar, S.; Chatila, W. K.; Schultz, N.; Yaeger, R.
    Gastroenterology (2020)

    Fulltext@MSK | Save
  • Accelerating precision medicine in metastatic prostate cancer
    Editorial

    Mateo, J.; McKay, R.; Abida, W.; Aggarwal, R.; Alumkal, J.; Alva, A.; Feng, F.; Gao, X.; Graff, J.; Hussain, M.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Dickkopf-1 can lead to immune evasion in metastatic castration-resistant prostate cancer
    Journal Article

    Wise, D. R.; Schneider, J. A.; Armenia, J.; Febles, V. A.; McLaughlin, B.; Brennan, R.; Thoren, K. L.; Abida, W.; Sfanos, K. S.; De Marzo, A. M.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria
    Meeting Abstract

    Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Progression-free survival estimates in non-small cell lung cancer when RECIST is unavailable: Project GENIE's integration of genomic, therapeutic and phenomic data
    Meeting Abstract

    Lavery, J. A.; Panageas, K.; LeNoue-Newton, M.; Sweeney, S.; Sheffler-Collins, S.; Rudolph, J. E.; Rizvi, H.; Schultz, N.; Lepisto, E. M.; Kehl, K. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and tissue concordance of BRCA2 copy number loss evaluated by single-cell, shallow whole genome sequencing of circulating tumor cells (CTCs) in castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Barnett, E.; Schonhoft, J.; Schultz, N. D.; Lee, J.; Zaidi, S.; Abida, W.; Carmichael, T.; Dago, A. E.; Solit, D. B.; Wenstrup, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
    Journal Article

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Next-generation sequencing of Bacille Calmette-Guerin (BCG)-unresponsive tumors identifies actionable alterations for potential targeted therapy in non-muscle invasive bladder cancer
    Meeting Abstract

    Walasek, A.; Almassi, N.; McPherson, V.; Dason, S.; Benfante, N.; Klein, T.; Berger, M. F.; Schultz, N.; Dalbagni, G.; Bajorin, D. F.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save